Search results for "Brain disease"

showing 4 items of 74 documents

Hyperammonemic encephalopathy after urinary diversion. Diet therapy

2016

medicine.medical_specialtyDiet therapymedicine.medical_treatment030232 urology & nephrologyUrinary DiversionPlant Proteins DietaryGastroenterologyIntestinal absorption03 medical and health sciencesEpilepsy Complex Partial0302 clinical medicineAmmoniaInternal medicinemedicineHumansHyperammonemia030212 general & internal medicineAgedAcidosisCarcinoma Transitional CellCARCINOMA TRANSITIONAL CELLBrain Diseases Metabolicbusiness.industryUrinary diversionHyperammonemiaHydrogen-Ion Concentrationmedicine.diseaseSurgeryIntestinal AbsorptionUrinary Bladder NeoplasmsFemaleDietary Proteinsmedicine.symptomAcidosisHyperammonemic encephalopathybusinessEndocrinología y Nutrición (English Edition)
researchProduct

Non-alcoholic Wernicke's encephalopathy: From MRI findings of a case to differential diagnosis checklist

2018

Wernicke's encephalopathy is a serious neurological disorder secondary to thiamine deficiency in alcoholics. However, rarely it affects non-alcoholics. Here we present a case of Wernicke's encephalopathy in a non-alcoholic 56-year-old female, treated by endoscopic surgery for a duodenal ulcer two years before. She came to our attention for a sudden onset of a neurological syndrome characterized by visual deficits, diplopia, confusion, spatial disorientation and loss of short-term memory. An MRI scan showed the typical MRI findings of Wernicke's encephalopathy, which are discussed together with the possible differential diagnosis.

medicine.medical_specialtyDiffusion-weighted magnetic resonance imagingWernicke Encephalopathymedicine.diagnostic_testWernicke encephalopathybusiness.industryMetabolic brain diseaseMedicine (all)Magnetic resonance imagingNon alcoholicGeneral Medicinemedicine.diseaseDiffusion-Weighted Magnetic Resonance ImagingChecklistWernicke's encephalopathyMagnetic resonance imagingThiamine deficiencymedicineRadiologyDifferential diagnosisbusinessMri findings
researchProduct

Will it ever become possible to prevent dopaminergic neuronal degeneration?

2008

Parkinsons disease (PD) is the second leading age-related degenerative brain disease in the world affecting millions of people. This neurological disorder disrupts the quality of life of patients and their families, exerts an enormous emotional and physical strain on caregivers, and has a large cost for society. Moreover, the increasing numbers of elderly people in the population will result in a sharp increase in the prevalence of PD. The understanding of its pathophysiology and treatment has advanced at a very impressive rate during past decades. Nevertheless, PD is still fatal and there is at present no cure for it. Furthermore, there are no proven therapies for prevention of PD and alth…

medicine.medical_specialtyDopaminePopulationNeurological disorderDiseaseNeuroprotectionSettore BIO/09 - FisiologiaNeuroprotective agentsRisk FactorsmedicineAnimalsHumansNeuronal degenerationNeurodegeneration Neuroprotection Parkinson's diseaseIntensive care medicineeducationPharmacologyNeuronseducation.field_of_studyCell Deathbusiness.industryGeneral NeuroscienceDopaminergicNeurodegenerative DiseasesParkinson's disease -- Treatmentmedicine.diseaseBrain diseaseNeuroprotective AgentsDrug developmentbusinessNervous system -- Degeneration
researchProduct

Stroke is now a brain disease: Revising ICD-11

2017

medicine.medical_specialtybusiness.industryMEDLINE030204 cardiovascular system & hematologymedicine.diseaseBrain disease03 medical and health sciences0302 clinical medicineNeurologyEmergency medicineMedicine030212 general & internal medicineNeurology (clinical)businessStrokeRevue Neurologique
researchProduct